Mitratapide is a medicine used in the treatment of conditions such as chronic liver disease (non-alcoholic steatohepatitis), non-alcoholic fatty liver disease, and primary biliary cholangitis. It works by blocking the production of cholesterol in the liver and reducing the amount of fat stored in the liver. This can help improve liver function and reduce the risk of serious complications such as cirrhosis and liver cancer. Mitratapide is taken orally and can be used in combination with other medications.
Mitratapide is a veterinary medication specifically used to manage overweight and obesity in dogs. It's important to note that it's not currently used in humans. Here's a closer look at its characteristics:
Function:
- Mitratapide works by inhibiting an enzyme called microsomal triglyceride transfer protein (MTP).
- MTP plays a crucial role in the absorption of dietary fats in the intestines.
- By blocking MTP, Mitratapide reduces the amount of fat absorbed from food, leading to weight loss in dogs.
Applications:
- Mitratapide is sold under the brand name Yarvitan and was previously authorized for use in the European Union (EU) to help dogs lose weight.
- However, it's important to note that Mitratapide has since been withdrawn from the market in the EU.
Important Considerations:
- While Mitratapide showed promise in promoting weight loss for dogs, its marketing authorization was withdrawn due to concerns about its long-term safety and potential side effects.
- It's crucial to consult a veterinarian before considering any weight loss regimen for your dog. They can recommend a safe and effective approach based on your dog's individual needs.